Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.3594
-0.0122 (-3.28%)
At close: May 12, 2025, 4:00 PM
0.3586
-0.0008 (-0.22%)
After-hours: May 12, 2025, 7:59 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $52.46 million as of May 12, 2025. Its market cap has decreased by -63.36% in one year.
Market Cap
52.46M
Enterprise Value
89.60M
1-Year Change
-63.36%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $52.46M, a decrease of -84.40%. That is a compound annual growth rate of -33.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 54.25M | -75.63% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |